| Anti-inflammatory drugs as anticancer agents S Zappavigna, AM Cossu, A Grimaldi, M Bocchetti, GA Ferraro, ... International journal of molecular sciences 21 (7), 2605, 2020 | 348 | 2020 |
| Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours AM Cossu, L Mosca, S Zappavigna, G Misso, M Bocchetti, F De Micco, ... International Journal of Molecular Sciences 20 (14), 3444, 2019 | 83 | 2019 |
| LncRNAs and immunity: coding the immune system with noncoding oligonucleotides M Bocchetti, M Scrima, F Melisi, A Luce, R Sperlongano, M Caraglia, ... International journal of molecular sciences 22 (4), 1741, 2021 | 47 | 2021 |
| Overview on molecular biomarkers for laryngeal cancer: looking for new answers to an old problem M Falco, C Tammaro, T Takeuchi, AM Cossu, G Scafuro, S Zappavigna, ... Cancers 14 (7), 1716, 2022 | 44 | 2022 |
| p53: from fundamental biology to clinical applications in cancer M Capuozzo, M Santorsola, M Bocchetti, F Perri, M Cascella, V Granata, ... Biology 11 (9), 1325, 2022 | 43 | 2022 |
| MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer C Ferri, A Di Biase, M Bocchetti, S Zappavigna, S Wagner, P Le Vu, ... Journal of Experimental & Clinical Cancer Research 41 (1), 20, 2022 | 42 | 2022 |
| The role of microRNAs in development of colitis-associated colorectal cancer M Bocchetti, MG Ferraro, F Ricciardiello, A Ottaiano, A Luce, AM Cossu, ... International Journal of Molecular Sciences 22 (8), 3967, 2021 | 40 | 2021 |
| Insight toward the MicroRNA profiling of laryngeal cancers: Biological role and clinical impact T Takeuchi, H Kawasaki, A Luce, AM Cossu, G Misso, M Scrima, ... International Journal of Molecular Sciences 21 (10), 3693, 2020 | 36 | 2020 |
| miR-125b upregulates miR-34a and sequentially activates stress adaption and cell death mechanisms in multiple myeloma G Misso, MR Zarone, A Lombardi, A Grimaldi, AM Cossu, C Ferri, ... Molecular Therapy-Nucleic Acids 16, 391-406, 2019 | 35 | 2019 |
| Gene interference strategies as a new tool for the treatment of prostate cancer M Boccellino, C Alaia, G Misso, AM Cossu, G Facchini, R Piscitelli, ... Endocrine 49, 588-605, 2015 | 29 | 2015 |
| Definition of miRNA signatures of nodal metastasis in LCa: miR-449a targets notch genes and suppresses cell migration and invasion H Kawasaki, T Takeuchi, F Ricciardiello, A Lombardi, E Biganzoli, ... Molecular Therapy-Nucleic Acids 20, 711-724, 2020 | 28 | 2020 |
| The 1, 4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells S Zappavigna, M Scuotto, AM Cossu, D Ingrosso, M De Rosa, C Schiraldi, ... Journal of Experimental & Clinical Cancer Research 35, 1-14, 2016 | 24 | 2016 |
| Optimal management of prostate cancer based on its natural clinical history G Facchini, F Perri, G Misso, C D'Aniello, GDV Scarpati, S Rossetti, ... Current cancer drug targets 18 (5), 457-467, 2018 | 21 | 2018 |
| Urotensin‐II‐Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells S Zappavigna, M Abate, AM Cossu, S Lusa, V Campani, L Scotti, A Luce, ... Journal of Oncology 2019 (1), 9293560, 2019 | 18 | 2019 |
| Lanreotide induces cytokine modulation in intestinal neuroendocrine tumors and overcomes resistance to everolimus C Sciammarella, A Luce, F Riccardi, C Mocerino, R Modica, M Berretta, ... Frontiers in Oncology 10, 1047, 2020 | 15 | 2020 |
| A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ROS-dependent unfolded protein response in human glioblastoma S Zappavigna, AM Cossu, M Abate, G Misso, A Lombardi, M Caraglia, ... International Journal of Molecular Sciences 20 (15), 3836, 2019 | 14 | 2019 |
| KRAS mutational regression is associated with oligo-metastatic status and good prognosis in metastatic colorectal cancer A Ottaiano, G Nasti, M Santorsola, V Altieri, G Di Fruscio, L Circelli, A Luce, ... Frontiers in Oncology 11, 632962, 2021 | 10 | 2021 |
| Chitosan-based polyelectrolyte complexes for doxorubicin and Zoledronic acid combined therapy to overcome multidrug resistance S Giarra, S Zappavigna, V Campani, M Abate, AM Cossu, C Leonetti, ... Pharmaceutics 10 (4), 180, 2018 | 10 | 2018 |
| Poorly Differentiated Neuroendocrine Larynx Carcinoma: Clinical Features and miRNAs Signature—A New Goal for Early Diagnosis and Therapy? F Ricciardiello, M Falco, G Tortoriello, F Riccardi, R Pellini, B Iorio, ... Journal of Clinical Medicine 10 (9), 2019, 2021 | 8 | 2021 |
| Genomic characterization of the emerging SARS-CoV-2 lineage in two districts of Campania (Italy) using next-generation sequencing M Scrima, AM Cossu, EL D'Andrea, M Bocchetti, Y Abruzzese, ... Frontiers in Virology 2, 814114, 2022 | 6 | 2022 |